UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Short‐ and long‐term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK

British journal of surgery, 2020-06, Vol.107 (7), p.896-905

2020

Volltextzugriff (PDF)

Liver transplantation outcomes after transarterial chemotherapy for hepatocellular carcinoma

British journal of surgery, 2020-08, Vol.107 (9), p.1183-1191

2020

Volltextzugriff (PDF)

Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (10), p.1113-1134

2012

Volltextzugriff (PDF)

Lactate and adrenergic signalling in trauma

Annals of the Royal College of Surgeons of England, 2016-03, Vol.98 (3), p.238-239

2016

Volltextzugriff (PDF)

Predictors of recurrence following laparoscopic minor hepatectomy for hepatocellular carcinoma in the UK

Surgical oncology, 2023-08, Vol.49, p.101965-101965, Article 101965

2023

Volltextzugriff (PDF)

Does Preoperative Beta-blocker Use Influence Intraoperative Hemodynamic Profile and Post-operative Course of Liver Transplantation?

Transplantation proceedings, 2016, Vol.48 (1), p.111-115

2016

Volltextzugriff (PDF)

Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies

International journal of clinical practice (Esher), 2011-02, Vol.65 (2), p.182-188

2011

Volltextzugriff (PDF)

Patients who Underwent Percutaneous Coronary Intervention Prior to Liver Transplantation Did Not Experience Bleeding Complications Whilst on Dual Antiplatelet Therapy

Journal of hepatology, 2016, Vol.64 (2), p.S541-S542

2016

Volltextzugriff (PDF)

Outpatient Liver Transplantation Assessment is an Effective Tool with No Evidence of Delay in Decision Making

Journal of hepatology, 2016, Vol.64 (2), p.S541-S541

2016

Volltextzugriff (PDF)

P0587 : Can hepatitis B surface antigen level predict severity of liver disease in genotype E patients?

Journal of hepatology, 2015-04, Vol.62, p.S536-S536

2015

Volltextzugriff (PDF)

P0500 : HIV and hepatitis delta - the last challenge in the viral hepatitides?

Journal of hepatology, 2015-04, Vol.62, p.S502-S502

2015

Volltextzugriff (PDF)

MER Tyrosine Kinase Positive Tumour Associated Macrophages Are a Novel Therapeutic Target in Hepatocellular Carcinoma

Journal of hepatology, 2016, Vol.64 (2), p.S574-S575

2016

Volltextzugriff (PDF)

Contrast-enhanced ultrasound liver imaging reporting and data system: clinical validation in a prospective multinational study in North America and Europe

Hepatology (Baltimore, Md.), 2024-02, Vol.79 (2), p.380-391

2024

Volltextzugriff (PDF)

Validation of Mesiah Score System in Patients with Hepatocellular Carcinoma

Journal of hepatology, 2016, Vol.64 (2), p.S330-S331

2016

Volltextzugriff (PDF)

459 THE SIGNIFICANCE OF VIRAL AND SEROLOGICAL MARKERS IN PREDICTING LIVER DISEASE SEVERITY IN E-AG NEGATIVE HEPATITIS B VIRUS INFECTION

Journal of hepatology, 2012-04, Vol.56, p.S181-S182

2012

Volltextzugriff (PDF)

Patient perception of skin-cancer prevention and risk after liver transplantation

Clinical and experimental dermatology, 2013-12, Vol.38 (8), p.851-856

2013

Volltextzugriff (PDF)

Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC

Abdominal radiology (New York), 2024-08, Vol.49 (8), p.2639-2649

2024

Volltextzugriff (PDF)

P60 Pre-treatment IP-10 concentrations are associated with a sustained virological response in HIV/HCV co-infected patients

Gut, 2011-09, Vol.60 (Suppl 2), p.A28-A28

2011

Volltextzugriff (PDF)

175 LOW ACCELERATING DOSE INDIVIDUALISED DURATION TREATMENT REGIMEN FOR RECURENT HCV POST LIVER TRANSPLANTATION

Journal of hepatology, 2012-04, Vol.56, p.S76-S76

2012

Volltextzugriff (PDF)

P34 No effect of tenofovir or entecavir on vitamin D levels in Chronic Hepatitis B mono-infected patients. Single centre ‘real life’ cohort experience

Gut, 2011-09, Vol.60 (Suppl 2), p.A15-A16

2011

Volltextzugriff (PDF)

P77 A Pharmacist delivered stratified conversion protocol from Hepatitis B Immunoglobulin (HBIG) to tenofovir or entecavir is efficacious, safe and cost-effective for prevention of recurrence of Hepatitis B virus (HBV) in Liver Transplant (LT) recipients

Gut, 2011-09, Vol.60 (Suppl 2), p.A35-A36

2011

Volltextzugriff (PDF)

P47 De-novo antiviral therapy with nucleos(t)ide analogues in ‘real-life’ patients with chronic hepatitis B infection: comparison of virological responses between lamivudine + adefovir vs entecavir vs tenofovir therapy

Gut, 2011-09, Vol.60 (Suppl 2), p.A22-A23

2011

Volltextzugriff (PDF)

706 MUTATION RTA181T/SW172 IS ASSOCIATED WITH LOWER HBSAG LEVELS THAN OTHER MUTATIONS IN HBV POLYMERASE CODON 181 AND OVERLAPPING SURFACE CODON 172 -IMPLICATIONS FOR VACCINATION?

Journal of hepatology, 2011-03, Vol.54, p.S283-S284

2011

Volltextzugriff (PDF)

407 EARLY ON-TREATMENT HAEMATOLOGICAL PARAMETERS AND GENOTYPE PREDICT RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C CIRRHOSIS

Journal of hepatology, 2011-03, Vol.54, p.S163-S164

2011

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(163)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(192)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Short‐ and long‐term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK

Liver transplantation outcomes after transarterial chemotherapy for hepatocellular carcinoma

Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma

Lactate and adrenergic signalling in trauma

Predictors of recurrence following laparoscopic minor hepatectomy for hepatocellular carcinoma in the UK

Does Preoperative Beta-blocker Use Influence Intraoperative Hemodynamic Profile and Post-operative Course of Liver Transplantation?

Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies

Patients who Underwent Percutaneous Coronary Intervention Prior to Liver Transplantation Did Not Experience Bleeding Complications Whilst on Dual Antiplatelet Therapy

Outpatient Liver Transplantation Assessment is an Effective Tool with No Evidence of Delay in Decision Making

P0587 : Can hepatitis B surface antigen level predict severity of liver disease in genotype E patients?

P0500 : HIV and hepatitis delta - the last challenge in the viral hepatitides?

MER Tyrosine Kinase Positive Tumour Associated Macrophages Are a Novel Therapeutic Target in Hepatocellular Carcinoma

Contrast-enhanced ultrasound liver imaging reporting and data system: clinical validation in a prospective multinational study in North America and Europe

Validation of Mesiah Score System in Patients with Hepatocellular Carcinoma

459 THE SIGNIFICANCE OF VIRAL AND SEROLOGICAL MARKERS IN PREDICTING LIVER DISEASE SEVERITY IN E-AG NEGATIVE HEPATITIS B VIRUS INFECTION

Inter-Reader Agreement for Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System Major Features and Final Categorization: A Subanalysis From a Prospective Multicenter Study

Patient perception of skin-cancer prevention and risk after liver transplantation

Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC

P60 Pre-treatment IP-10 concentrations are associated with a sustained virological response in HIV/HCV co-infected patients

175 LOW ACCELERATING DOSE INDIVIDUALISED DURATION TREATMENT REGIMEN FOR RECURENT HCV POST LIVER TRANSPLANTATION

P34 No effect of tenofovir or entecavir on vitamin D levels in Chronic Hepatitis B mono-infected patients. Single centre ‘real life’ cohort experience

P77 A Pharmacist delivered stratified conversion protocol from Hepatitis B Immunoglobulin (HBIG) to tenofovir or entecavir is efficacious, safe and cost-effective for prevention of recurrence of Hepatitis B virus (HBV) in Liver Transplant (LT) recipients

P47 De-novo antiviral therapy with nucleos(t)ide analogues in ‘real-life’ patients with chronic hepatitis B infection: comparison of virological responses between lamivudine + adefovir vs entecavir vs tenofovir therapy

706 MUTATION RTA181T/SW172 IS ASSOCIATED WITH LOWER HBSAG LEVELS THAN OTHER MUTATIONS IN HBV POLYMERASE CODON 181 AND OVERLAPPING SURFACE CODON 172 -IMPLICATIONS FOR VACCINATION?

407 EARLY ON-TREATMENT HAEMATOLOGICAL PARAMETERS AND GENOTYPE PREDICT RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C CIRRHOSIS

Suchergebnisse filtern